ArticleFrontiers in oncology2026

De-escalating the axilla: oncologic and morbidity outcomes of targeted axillary dissection versus axillary lymph node dissection following neoadjuvant systemic therapy in clinically node-positive breast cancer within a single institution.

Skylar Harbour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.